CDC40 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	26 studies	25% ± 8%	Explore
natural killer cell	18 studies	22% ± 7%	Explore
naive B cell	16 studies	22% ± 5%	Explore
memory B cell	16 studies	21% ± 4%	Explore
classical monocyte	13 studies	26% ± 12%	Explore
non-classical monocyte	13 studies	29% ± 14%	Explore
plasmacytoid dendritic cell	12 studies	30% ± 8%	Explore
gamma-delta T cell	12 studies	22% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	10 studies	22% ± 6%	Explore
endothelial cell	10 studies	22% ± 4%	Explore
CD16-positive, CD56-dim natural killer cell, human	9 studies	24% ± 7%	Explore
regulatory T cell	9 studies	19% ± 4%	Explore
CD8-positive, alpha-beta T cell	8 studies	23% ± 8%	Explore
glutamatergic neuron	8 studies	39% ± 24%	Explore
monocyte	7 studies	20% ± 3%	Explore
fibroblast	7 studies	21% ± 6%	Explore
mucosal invariant T cell	7 studies	18% ± 2%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	6 studies	20% ± 5%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	6 studies	21% ± 7%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	23% ± 8%	Explore
mature NK T cell	6 studies	20% ± 3%	Explore
epithelial cell	6 studies	32% ± 10%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	22% ± 5%	Explore
macrophage	6 studies	20% ± 3%	Explore
oligodendrocyte	6 studies	25% ± 6%	Explore
T cell	5 studies	20% ± 2%	Explore
precursor B cell	5 studies	31% ± 7%	Explore
retina horizontal cell	5 studies	20% ± 4%	Explore
CD4-positive, alpha-beta T cell	4 studies	27% ± 7%	Explore
immature B cell	4 studies	31% ± 10%	Explore
innate lymphoid cell	4 studies	19% ± 2%	Explore
GABAergic neuron	4 studies	38% ± 13%	Explore
astrocyte	4 studies	26% ± 8%	Explore
oligodendrocyte precursor cell	4 studies	24% ± 7%	Explore
effector CD8-positive, alpha-beta T cell	3 studies	19% ± 1%	Explore
leukocyte	3 studies	20% ± 3%	Explore
conventional dendritic cell	3 studies	38% ± 16%	Explore
neuron	3 studies	23% ± 4%	Explore
retinal bipolar neuron	3 studies	26% ± 3%	Explore
ciliated cell	3 studies	27% ± 6%	Explore
lymphocyte	3 studies	21% ± 6%	Explore
rod bipolar cell	3 studies	20% ± 5%	Explore
dendritic cell	3 studies	46% ± 24%	Explore
intestinal crypt stem cell	3 studies	16% ± 1%	Explore
basal cell	3 studies	30% ± 4%	Explore
transit amplifying cell	3 studies	26% ± 11%	Explore
interneuron	3 studies	43% ± 19%	Explore
double negative thymocyte	3 studies	28% ± 9%	Explore
abnormal cell	3 studies	22% ± 4%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	11 studies	25% ± 10%	Explore
brain	6 studies	39% ± 18%	Explore
lung	5 studies	20% ± 5%	Explore
eye	4 studies	22% ± 3%	Explore
intestine	3 studies	20% ± 3%	Explore
liver	3 studies	25% ± 10%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	1078.28	1445 / 1445	100%	15.35	183 / 183
lung	100%	1222.24	578 / 578	100%	13.18	1154 / 1155
intestine	100%	1202.82	966 / 966	100%	11.79	525 / 527
ovary	100%	1411.64	180 / 180	100%	8.92	428 / 430
breast	100%	1258.69	459 / 459	99%	16.48	1111 / 1118
stomach	100%	976.94	359 / 359	99%	12.86	284 / 286
bladder	100%	1169.67	21 / 21	99%	10.14	497 / 504
pancreas	100%	761.19	327 / 328	99%	9.22	176 / 178
brain	99%	1160.05	2615 / 2642	100%	12.26	702 / 705
thymus	100%	1333.51	653 / 653	99%	13.16	596 / 605
prostate	100%	1089.00	245 / 245	98%	12.60	493 / 502
uterus	100%	1266.28	170 / 170	97%	11.11	447 / 459
kidney	100%	952.10	89 / 89	97%	11.58	874 / 901
adrenal gland	100%	1832.64	258 / 258	95%	10.73	219 / 230
skin	100%	1362.66	1809 / 1809	92%	9.17	434 / 472
liver	100%	767.65	226 / 226	90%	5.68	364 / 406
adipose	100%	1299.10	1204 / 1204	0%	0	0 / 0
blood vessel	100%	1223.37	1335 / 1335	0%	0	0 / 0
spleen	100%	1520.85	241 / 241	0%	0	0 / 0
muscle	100%	1007.27	801 / 803	0%	0	0 / 0
tonsil	0%	0	0 / 0	98%	11.51	44 / 45
lymph node	0%	0	0 / 0	97%	11.27	28 / 29
heart	95%	698.11	816 / 861	0%	0	0 / 0
peripheral blood	94%	1371.08	876 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	76%	5.06	61 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0000398	Biological process	mRNA splicing, via spliceosome
GO_1990403	Biological process	embryonic brain development
GO_0016607	Cellular component	nuclear speck
GO_0071013	Cellular component	catalytic step 2 spliceosome
GO_0005654	Cellular component	nucleoplasm
GO_0071007	Cellular component	U2-type catalytic step 2 spliceosome
GO_0005515	Molecular function	protein binding
GO_0003729	Molecular function	mRNA binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	CDC40
Protein name	Cell division cycle 40 CDC40 protein Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)
Synonyms	PRPF17 EHB3 PRP17
Description	FUNCTION: Required for pre-mRNA splicing as component of the activated spliceosome . Plays an important role in embryonic brain development; this function does not require proline isomerization . .
Accessions	Q5SRN1 Q2TA76 ENST00000307731.2 ENST00000368932.5 ENST00000368930.5 O60508

CDC40 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review